Zomedica Pharmaceuticals
ZOM
$0.15
Share price
2.25%
Change (1 day)
-30.86%
Change (1 year)
Categories
Zomedica Pharmaceuticals (ZOM) - P/B ratio
P/B ratio as of May 2024 : 0.5928
According to Zomedica Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 0.5928.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Zomedica Pharmaceuticals - P/B ratio (from 2016 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 0.8174 | 36.83% |
| 2022-12-31 | 0.5974 | -46.12% |
| 2021-12-31 | 1.11 | -56.47% |
| 2020-12-31 | 2.55 | -85.07% |
| 2019-12-31 | 17.1 | -46.48% |
| 2018-12-31 | 31.9 | -20.81% |
| 2017-12-31 | 40.3 | 79.98% |
| 2016-12-31 | 22.4 | |
| 2015-12-31 | N/A | |
| 2014-12-31 | N/A | |
| 2013-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.92 | 392.81% | 🇺🇸 USA |